Further expansion for capital business
Scottish testing company Exova acquires US firm
No details of the transaction were disclosed.
SL Pharma has clients in North America, Australia, Europe and Japan and reported revenues of about $2.5m in 2016.
Exova operates from 135 laboratories and offices in 33 countries and employs around 4,200 staff.
It specialises in testing across a number of key sectors from aerospace to health sciences.
James R. Scull, Exova’s vice president, health sciences Americas, said: “This acquisition significantly enhances our technical expertise and service offering within the pharmaceutical market and complements our existing testing facilities in North America.”
Waheed Sheikh, president, SL Pharma, said: “Becoming part of a global testing and advisory business is a great move for SL Pharma, our team and our customers as it gives us access to new capabilities and expertise.
“I look forward to working with Exova to continue to grow the business and take the SL Pharma name and reputation to exceptional new levels.”